Scientists test new drug duo in fight against tough cancers
NCT ID NCT01582191
Summary
This early-stage trial tested two oral drugs, vandetanib and everolimus, given together to people with advanced cancer that had spread or stopped responding to standard treatments. The main goals were to find the safest dose of this combination and to understand its side effects. Researchers also wanted a first look to see if the drug pair could help control cancer growth.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED MALIGNANT NEOPLASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.